Our team conducted a review of all of the biotech mergers and acquisitions of 2021 and distilled it down to the acquisitions of drug discovery-focused biotechs here. There were 10 acquisitions of companies with large molecule drug assets in 2021. Here is a more in-depth look into all of the lead large molecules acquired in 2021, including a review of:
- The financial details of the acquisition/merger
- The mechanism of action and indication of each lead molecule
- The stage of clinical development for each lead molecule
Drug Discovery Biotech M&As: Large Molecules Deep Dive (Part 6)
request a trial
Drug Hunter is commited to helping industry innovators make informed decisions. Premium members have access to our library of the latest stories in science, written by scientists.
Request a trial to access insights powering the pros in our industry.